back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-09-07 10:36 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-366,965.80
-43,948 vol $8.35 each |
104,578 | |
| Filed 2023-09-07 10:33 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,043,441
+124,963 vol $8.35 each |
148,526 | |
| Filed 2023-09-07 10:29 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-124,963 vol |
460,355 | |
| Filed 2023-03-06 17:55 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-37,009.25
-4,001 vol $9.25 each |
23,563 | |
| Filed 2023-03-06 17:54 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$134,957
+14,590 vol $9.25 each |
27,564 | |
| Filed 2023-03-06 17:54 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-14,590 vol |
585,318 | |
| Filed 2023-03-06 17:53 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$1,319,771
+142,678 vol $9.25 each |
599,908 | |
| Filed 2023-03-06 17:51 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+123,177 vol |
512,907 | |
| Filed 2023-01-04 17:47 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,626.80
-6,310 vol $6.28 each |
12,974 | |
| Filed 2023-01-04 17:46 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$121,103
+19,284 vol $6.28 each |
19,284 | |
| Filed 2023-01-04 17:45 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-04 17:42 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-19,284 vol |
457,230 | |
| Filed 2022-09-08 11:05 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+374,891 vol |
476,514 |